Dr. Chattopadhyay received a B.S. degree in zoology from the University of Calcutta, India. She completed an M.S. in zoology and a Ph.D. in neurosciences at Jiwaji University, Gwalior, India. After finishing her post-doctoral training in the Department of Neurology at the University of Pittsburgh, she became a research assistant professor in the Department of Neurology at the University of Michigan.
Dr. Chattopadhyay joined the Center of Emphasis in Diabetes and Metabolism at TTUHSC El Paso in April 2014, as an assistant professor. Her research interests are in the areas of diabetic complications, obesity, sensory nerve disorders, and treatment with viral vector-mediated gene therapy. Her earlier work was focused on understanding the pathogenesis of painful neuropathies and development of novel treatments for this condition which involves the regulation of inhibitory neurotransmitter receptors and ion channel trafficking. Her lab is currently exploring the role of increased neuroimmune activation in the pathophysiology of Type 1 and Type 2 diabetic neuropathies. These studies emphasize to identify the specific cytokines/chemokines and their interaction with voltage gated ion channels which may lead to targeted therapeutic interventions for diabetic sensory neuropathy. Dr. Chattopadhyay's lab is also focused on understanding the role of neuroinflammation in the development of other diabetic complications in Type 1 and Type 2 diabetes, and whether exercise, as well as other alternative approaches, could alleviate the development of these complications. She is also interested in identifying the cluster of biomarkers and/or nutrient/micronutrient deficiency(ies) for early detection of obesity in the diverse border population (mainly Hispanics).